Alpha-Fetoprotein (AFP) and AFP-L3 Build info

Synonyms

• ALPHA FETOPROTEIN, L3 PERCENT
• AFP
• LAB664

Procedure Name

ALPHA FETOPROTEIN, L3 PERCENT

Procedure Master Number

LAB664

Procedure ID

56006

Clinical Info

The AFP-L3% assay is intended for use in the assessment of risk for the development of hepatocellular carcinoma (HCC) in patients with chronic liver diseases

Specimen Sources

Specimen Types

Container

Serum Seperator Tube

Collection Instructions

Container/Tube: Gold top tube
Specimen:  0.5 mL serum ( 0.2 mL min)
Rejection: Gross icterus
 

Specimen Volume

0.5 mL serum ( 0.2 mL min)

Transport Instructions

Refrigerated

Specimen Stability

9 Days Room Temperature or Refrigerated or Frozen
Rejection: Gross icterus
 

Methodology

Liquid-phase binding assay

Days Performed

TAT 2 - 4 Days

Performing Laboratory

LabCorp

CPT

82107

PDM

Only Orderable at Locations:

Results

Result Interpretation

Age	Male	Female
	AFP, Serum (ng/mL)	AFP, Serum (ng/mL)
0 to 7 d	0.0–75265.8	0.0–75265.8
8 to 30 d	0.0–32556.4	0.0–32556.4
1 m	0.0–1747.8	0.0–1600.3
2 m	0.0–391.1	0.0–550.0
3 m	0.0–225.8	0.0–339.9
4 m	0.0–230.6	0.0–230.6
5 m	0.0–118.0	0.0–234.0
6 m	0.0–97.2	0.0–97.2
7 to 11 m	0.0–60.3	0.0–60.3
1 y	0.0–21.4	0.0–21.4
2 y	0.0–9.4	0.0–10.1
3 to 4 y	0.0–5.5	0.0–5.5
5 y	0.0–3.6	0.0–4.2
6 to 12 y	0.0–3.9	0.0–3.9
13 to 17 y	0.0–4.3	0.0–4.3
18 to 30 y	0.0–5.7	0.0–4.7
31 to 50 y	0.0–6.9	0.0–6.4
51 to 80 y	0.0–8.4	0.0–9.2
>80 y	0.0–6.4	0.0–8.7
Reference Interval developed by in-house study. Normal values apply only to males and to nonpregnant females. These results are not interpretable for pregnant females.
AFP-L3%, Serum
All	0.0–9.9	0.0–9.9

Forms